<div id="readability-page-1">05:23 PM EST, 12/19/2025 (MT Newswires) -- John Johnson, Director, on December 19, 2025, sold 135,400 shares in Xeris Biopharma Holdings ( XERS ) for $977,019. Following the Form 4 filing with the SEC, Johnson has control over a total of 698,083 common shares of the company, with 698,083 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1867096/000141078125000006/xslF345X05/wk-form4_1766182662.xml MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

XERS

05:23 PM EST, 12/19/2025 (MT Newswires) -- John Johnson, Director, on December 19, 2025, sold 135,400 shares in Xeris Biopharma Holdings ( XERS ) for $977,019. Following the Form 4 filing with the SEC, Johnson has control over a total of 698,083 common shares of the company, with 698,083 shares held directly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

Xeris Biopharma Holdings Insider Sold Shares Worth $977,019, According to a Recent SEC Filing